39. MDR-TB: outcomes of treatment Friday, 31 October 2014, 10:15-11:15 Chair: Zohar Mor (Israel) Section: Tuberculosis PD-942-31 Risk factors associated with default among multidrug and extensively drug resistant tuberculosis patients in Georgia, 2013 M Gegia, I Kachkachishvili, N Korinteli, T Gabunia (Georgia) PD-943-31 An evaluation of tuberculosis retreatment in Brazil, 2007-2011 M.S. Evangelista, F. Dockhorn, R Maia, J Toledo, J N Lima, F Moherdaui, D Barreira (Brazil) PD-944-31 Loss to follow up and acquired drug-resistance during treatment of multidrug-resistant tuberculosis E Kurbatova, J Ershova, T Dalton, P Cegielski, and Global Petts Investigators (USA) PD-945-31 Risks of multi and extensively drug-resistant tuberculosis in patients with multiple previous treatments in rural China B Xu, Q Zhao, Yi Hu, Y Shi, W Wang, V Diwan (China) PD-946-31 Monitoring of MDR-TB treatment outcomes in the Russian Federation V Testov, I Vasilieva, Serg Sterlikov, V Erokhin, T Kasaeva (Russian Federation) PD-947-31 Amplified drug resistance and association with poor outcomes among patients with multidrugresistant tuberculosis R Kempker, M Kipiani, V Mirtskhulava, N Tukvadze, M Magee, H Blumberg (USA, Georgia) PD-948-31 Extensive drug resistance acquired during treatment of multidrug-resistant tuberculosis P Cegielski, T Dalton, J Campos Caoili, C C Contreras, J Ershova, E Kurbatova, C Kvasnovsky, and Global Petts Investigators (USA, Philippines, Peru, UK) PD-949-31 Impact of acquired drug resistance on treatment outcomes among patients treated for multidrugresistant tuberculosis P Cegielski, E Kurbatova, J Campos Caoili, C C Contreras, T Dalton, J Ershova, C Kvasnovsky, and Global Petts Investigators (USA, Philippines, Peru, UK) PD-950-31 Ability of early sputum culture conversion to predict long-term outcomes in an MDR-TB clinical trial P Meyvisch, A Gaddah, B Dannemann, K Andries, C Kambili, M Haxaire-theeuwes (Belgium, USA) PD-951-31 Time of sputum culture conversion of MDR-TB-HIV co-infected patients on second-line antituberculosis drugs N N Nwokoye, C C Onubogu, Phd, A Bowale, N Tochukwu, Segu Adesasen, O Idigbe (Nigeria) PD-952-31 Good treatment outcomes among prisoners with drug-resistant tuberculosis: hope from Baku, Azerbaijan and a challenge to the TB world R Mekhdiyev, C Auer, E Gurbanova, F Huseynov, N. Rakhmanov, N. Karimova, R Tahirli, G B Migliori (Azerbaijan, Switzerland, Italy) PD-953-31 Trend of the drug-resistance surveillance in Thailand, 199-2012 S Rienthong, D Rienthong, C Boonin, N Phothong, C Namwat (Thailand)